Name: Toxogonin (chlorure d'obidoxime) 250 mg
Creator: Department of National Defence

Full description

Department of National Defence, has a requirement for Toxogonin (Obidoxime chloride) 250 mg for the treatment of Canadian Armed Forces (CAF) members who may have been exposed to chemical warfare agents.The period of the Contract is from date of Contract to 31 March 2024 inclusive.Initial Requirement: The Contractor must supply 4,110 vials or ampoules no later than 31 March 2022.Optional Requirementsa. Optional Requirement 1: The Contractor must supply up to 4,110 vials or ampoules no later than 31 March 2023.b. Optional Requirement 2: The Contractor must supply up to 4,110 vials or ampoules no later than 31 March 2024.

AI Analysis

Get a plain-English breakdown of this tender — what they need, who can bid, how to approach it, and tips for small suppliers. Takes a couple of seconds.

Basic information

Reference

PW-21-00979021

Solicitation no.

W6369-22-A052

Buyer

Department of National Defence

Notice type

Request for Proposal

Method

Competitive - Open bidding

Procurement category

*GD

Trade agreements

*Canada-Honduras Free Trade Agreement *Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP) *World Trade Organization Agreement on Government Procurement (WTO GPA) *Canada-Colombia Free Trade Agreement *Canada-Peru Free Trade Agreement (CPFTA) *Canada-Panama Free Trade Agreement *Canada-European Union Comprehensive Economic and Trade Agreement (CETA) *Canada-Korea Free Trade Agreement (CKFTA) *Canada-UK Trade Continuity Agreement (Canada-UK TCA) *Canadian Free Trade Agreement (CFTA) *Canada-Chile Free Trade Agreement (CCFTA) *Canada-Ukraine Free Trade Agreement (CUFTA)